15 Dec 2021

Updated 15 Dec 2021

Amplifying Data Science Tools for End-to-End eClinical Solutions


Amplifying Data Science Tools for End-to-End eClinical Solutions

On December 7th, Andreas Weber, Group CEO at EvidentIQ, sat down with Natalie Yeadon, Co-Founder & CEO at Impetus Digital to discuss hybrid vs. fully decentralized trials, the use of real-world evidence (RWE) in clinical trials, and how an end-to-end eClinical solution can help meet increasing customer demand across clinical operations and clinical data management, plus much more!

This live session was organized by Impetus Digital, the spark behind sustained healthcare stakeholder communication, collaboration, education, and insight synthesis. You can watch the full webinar by clicking below or listen to the podcast version if you’re on the go.

Contact us for more information: info@evidentiq.com 

Get a Demo

Let us show you how we can help you.

Get a Quote

Discover a solution tailored to your needs and budget.

Get a Meeting

Let’s start a new project together!

Let’s Start
a conversation

Ready to discover how our platform and its suite of applications can meet your needs?


    We use cookies to personalize content and ads, provide social media features, and analyze traffic to our website. Our partners may combine this information with other data they have provided to you or collected from your use of the services. Because we value your privacy, we hereby request your permission to use the following technologies. You may change / revoke your consent later at any time by clicking on the settings in the lower left corner of the page.

    Please note that according to a recent ruling by the European Court of Justice (ECJ), there is no adequate level of data protection in the USA and therefore a risk to the protection of your data. For example, under certain conditions, your data may be processed by US authorities for control and monitoring purposes. In addition, we currently refer to Art. 49 GDPR with regard to the legal basis for the transfer of data. After implementation of the new EU standard data protection clauses, these will constitute the legal basis for data transfer to third countries.